Onset of Sarcoidosis in Patients on Biologic Therapy: A Systematic Review

Abstract

Keywords

sarcoidosis drug adverse reactions biologics TNF-alpha inhibitor anti-CD20

Get full access to this article

View all access options for this article.

References

Shah

Drucker

AM.

Shear

NH.

Ziv

Dodiuk-Gad

. Granulomatous cutaneous drug eruptions: a systematic review. Am J Clin Dermatol. 2021;22(1):39-53.doi:10.1007/s40257-020-00566-4

33108647

Facco

Cabrelle

Teramo

et al. Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax. 2011;66(2):144-150.doi:10.1136/thx.2010.140319

21139119

Alazemi

Campos

. Interferon-Induced sarcoidosis. Int J Clin Pract. 2006;60(2):201-211.doi:10.1111/j.1742-1241.2005.00651.x

16451294

Lamrock

Brown

. Development of cutaneous sarcoidosis during treatment with tumour necrosis alpha factor antagonists. Australas J Dermatol. 2012;53(4):e87-e90.doi:10.1111/j.1440-0960.2011.00863.x

23157794

Vigne

Tebib

J-G.

Pacheco

Coury

. Sarcoidosis: an underestimated and potentially severe side effect of anti-TNF-alpha therapy. Joint Bone Spine. 2013;80(1):104-107.doi:10.1016/j.jbspin.2012.05.001

22885144

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.04 MB

0.19 MB

0.35 MB

0.16 MB